头孢他美酯治疗急性泌尿系统感染临床疗效分析

Analysis of clinical curative effects of cefetamet pivoxil on acute urinary system infected patients

目的:分析头孢他美酯(cefetamet pivoxil)治疗急性泌尿系统感染的临床疗效。方法:20例急性泌尿系统感染患者随机分为两组,分别使用头孢他美酯和阿莫西林-克拉维酸钾片(奥格门,Augmemtin)治疗。 A组:头孢他美酯治疗(n=10),每次250mg,早、晚饭后各服1次,B组:阿莫西林-克拉维酸钾片治疗(n= 10),每次375mg,每日3次,饭后服用。两组疗程均为 7d。对有效率、痊愈率,尿中白细胞清除率等方面进行评价。结果:两组治疗有效率分别为80％和90％;痊愈率分别为70％和80％;尿中白细胞的清除率分别为70％和80％。治疗中B组发生副反应1例。经统计分析,A、B两组间的药效及安全性无显著差异(P>0．05)。结论:头孢他美酯是治疗急性泌尿系统感染的有效药物,值得临床推广使用。

Objective： To analyze the clinical curative effects of cefelamet pivoxil on acute urinary system infected patients. Methods：20 acute urinary system infected patients were randomly divided into two groups： group A （n= 10） , in which the patients were treated with cefetamet pivoxil （250mg, po, hid, pc） for 7 days, and group B（ n = 10）, in which the patients were administrated with amoxicillin-elavulante （375mg, po, rid, pc） for 7days. The clinical effective rate, recovery rate and WBC clearance rate in urine were statistically evaluated. Results： The clinical effective rates of group A and gronp B were 80% and 90% , respectively. The recovery tatcs of group A and group B were 70% and 80% , respectively. The WBC clearance rates in urine of group A and group B were 70% and 80%, respectively One side effect case occurred in group B. There was no significant difference statistically between two groups （P 〉 0.05）. Conclusion： Cefetamet Pivoxil is efficient to treat acute urinary tract infection.